Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR)
Outstanding Shares: 74.17M
Analysis: Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR)’s latest press release responds to Silence Therapeutics plc becoming the new minority stakeholder of the company by now holding 6,000,359 Arrowhead shares. ARWR will remain focused on their company goals as the company has been bullish since mid-December.
Arrowhead Pharmaceuticals, Inc. (ARWR) today responded to the announcement by Silence Therapeutics plc that it acquired, in the open-market, an equity stake of 6,000,359 Arrowhead shares, representing 8.4% of the common shares outstanding. Arrowhead was advised of this just prior to the announcement by Silence. Continue Reading
UPTICK Newswire LLC is not an investment advisor. Investors are strongly encouraged to do their own due diligence and review all company documents and press releases to ensure the company noted above fits their own investment qualifications.
Source: Uptick Newswire